• Clinical Consideration for the Treatment of GSM
    Dr Nick Panay, MSc, MBBS, FRCOG, MFSHR Honorary Senior Lecturer, Imperial College Director, West London Menopause and PMS Center Queen Charlotte’s and Chelsea Westminster Hospitals General Secretary-Elect of the International Menopause Society Dr Panay reviews why discussion of treatment options f... Read more..
  • Moisturizers, Lubricants, and Prasterone
    Dr Nick Panay, MSc, MBBS, FRCOG, MFSHR Honorary Senior Lecturer, Imperial College Director, West London Menopause and PMS Center Queen Charlotte’s and Chelsea Westminster Hospitals General Secretary-Elect of the International Menopause Society Dr Panay discusses the importance of talking about pai... Read more..
  • Heavy Menstrual Bleeding Clinical Care Standard 2017
    7 December 2017:  The first nationally agreed standard of care for women with heavy menstrual bleeding was launched by the Australian Commission on Safety and Quality in Health Care on 20 October 2017. The new standard aims to improve women’s health across Australia for this potentially debili... Read more..
  • The Timing Hypothesis
    Dr Peter Schnatz Past President of NAMS and Associate Chairman and Residency Program Director in the Department of Obstetrics and Gynecology at the Reading Hospital in Reading, Pennsylvania. Dr Schnatz discusses the benefits of starting women on hormone therapy at the beginning of the menopause tr... Read more..
  • Common Cognitive Complaints
    Dr Victor Henderson Past President, The North American Menopause Society Professor, Health Research and Policy and Neurology and Neurological Sciences Stanford University Director, Alzheimer’s Disease Research Center Stanford, CA Dr Hendersen explains cognitive complaints as it relates to ageing a... Read more..
  • Changes before the Change: World Menopause Day 2017
    18 October 2017 Changes before the Change: Perimenopausal bleeding Although some women may abruptly stop having periods leading up to the menopause, many will notice changes in patterns and irregular bleeding. Whilst this can be a natural phase in your life, it may important to see your he... Read more..
  • Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials
    Abstract Importance: Health outcomes from the Women's Health Initiative Estrogen Plus Progestin and Estrogen-Alone Trials have been reported, but previous publications have generally not focused on all-cause and cause-specific mortality. Objective: To examine total and c... Read more..
  • Bleeding – perimenopausal, postmenopausal and breakthrough bleeding on MHT/HRT
    Key points A change in bleeding pattern is common during perimenopause. Heavy bleeding, prolonged bleeding, and any bleeding more than 12 months after the last menstrual period need investigation. Endometrial ultrasound is the first investigation of choice, and the findings determine th... Read more..
  • Early Menopause: Using the Experiences and Perspectives of Women and Health Professionals to Translate Evidence into Practice
    Description of Study This research project is being conducted by RMIT University, the Monash Centre for Health Research and Implementation (Monash University) and other partners. We are interested in the experiences of women with early or premature menopause, and the perspectives of health professi... Read more..
  • NAMS 2017 position statement updates guidelines for hormone therapy use
    A new position statement on the use of hormone therapy (HT) for menopausal and postmenopausal women from The North American Menopause Society (NAMS) has been published online today in the Society's journal, Menopause. "The use of hormone therapy continues to be one of the most controversial and deba... Read more..
  • Perimenopausal and Postmenopausal Bleeding
    Dr Steven Goldstein Past President of NAMS, Professor of Obstetrics and Gynecology at New York University School of Medicine, and Co-Director of the Bone Densitometry and Body Composition unit at the NYU Langone Medical Center. Dr Goldstein discusses the required action for any spotting, staining,... Read more..
  • Fact Sheets
    The AMS website is often the first port of call for patients. With this in mind we have decided to create a set of fact sheets for patients, as companion sheets to the popular videos, and the other more detailed AMS Information Sheets. Menopause what are the symptoms? Menopause at a glance Ev... Read more..
  • The evidence base for HRT: what can we believe?
    See Editor-in-Chief Climacteric Rod Baber's editorial concerning this paper here. Abstract Prior to the unexpected early termination of the Women’s Health Initiative (WHI) trial of continuous conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA), the prevailing view was that horm... Read more..
  • Bone Drug Holidays
    Dr Michael McClung NAMS Board Member and Founding Director of The Oregon Osteoporosis Center in Portland, Oregon. Dr McClung discusses what the possible long-term risk of bisphosphonates for bone health are and who may be ideal candidates for a drug holiday. He also shares what options are availab... Read more..
  • What is scientific truth?
    Rod Baber  Editor-in-Chief Climacteric  In 2002, “Risks and benefits of estrogen plus progestin in healthy postmenopausal women” was the first paper published from the Women’s Health Initiative (WHI) study. Unlike previous observational studies, the data were suggestive of harm. The paper... Read more..